mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.088 |
0.04 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.04 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.083 |
0.05 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.32 |
0.05 |